Gastroenterology Center of the MidSouth

Memphis, Tennessee 38120

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease

Studies at this site

• Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease — Completed
• Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease — Completed
• Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease — Completed